ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Beam Therapeutics
The Senior Director, Value, Evidence & Development Strategy will lead global HEOR and evidence-generation strategy for Beam’s sickle cell disease program (risto-cel) and emerging pipeline programs. This senior leader will shape external engagement, cross-functional alignment, and strategic planning to support development, regulatory interactions, and reimbursement pathways. The role partners closely with Clinical Development, Medical Affairs, Commercial, and R&D to inform program priorities and evidence needs.
Headquarters
Cambridge, Massachusetts, United States
Company Size
501-1000 employees
Founded
2017
Beam Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, pioneering precision genetic medicines using its proprietary base editing platform to make precise single‑base DNA changes without creating double‑strand breaks. The company advances both in vivo and ex vivo programs across hematology, rare genetic diseases, and oncology, moving several candidates toward clinical development. Beam combines engineered editors, delivery technologies, and extensive safety profiling to create durable, potentially one‑time treatments and partners with academic and industry collaborators to accelerate translation.
TradingViewBeam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?
10 hours ago
Simply Wall StBeam Therapeutics (BEAM) Leverages New Financing And IP Control Is Its Gene-Editing Edge Strengthening?
3 days ago
GlobeNewswireBeam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Beam Therapeutics.
Fierce BiotechAfter gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
2 weeks ago
RWE Strategy Lead Developed Brands, Immunology
UCB
Director, Global Real-World Evidence & Health Outcomes Research Scientist
GSK plc
Director, US Real-World Evidence & Health Outcomes Research Scientist Hematology-Oncology
GSK plc
Executive Director, Global HEOR - Cell Therapy,
Bristol Myers Squibb
Associate Director, Global Health Economics and Outcomes Research (GHEOR) Neuroscience
Bristol Myers Squibb
Director, HEOR Strategy, Global Immunology Pipeline
AbbVie
